Danish drugmaker Novo Nordisk will invest 8.5 billion crowns ($1.20 billion) in a new facility in Odense, Denmark, for the ...

By Anna Ringstrom and Maggie Fick STOCKHOLM/LONDON (Reuters) -Danish drugmaker Novo Nordisk will invest 8.5 billion crowns ...

Millions of diabetes patients have to take a painful insulin injection to keep sugar levels in control. Cipla is introducing ...

Patients at a community health center who had type 2 diabetes and a high risk of atherosclerotic cardiovascular disease (ASCVD) were under-prescribed guideline-recommended treatment with ...

Mike Plante struggled with his weight for years, but within six months of starting with the injection drug semaglutide, a ...

Mike Plante struggled with his weight for years, but within six months of starting with the injection drug semaglutide, a medication for diabetes that’s also being used for weight-loss, he’s down 65 ...

1 Eydenzelt, previously known as CT-P42, is a 40 mg/mL solution for injection available in a vial and as a prefilled syringe.

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Much hype surrounds drugs called GLP-1 agonists but they are intended for diabetes patients and people who are obese, not ...

Today's health news includes an exit interview with the CDC's Mandy Cohen, the average BMI in the US declined in 2023, and ...

Landmark publication in leading ophthalmology research journal demonstrates the power of 4DMT’s Therapeutic Vector Evolution platform to invent ...

The factories in Italy, Belgium and the U.S. are intended to boost Novo’s popular GLP-1 weight loss drugs Ozempic and Wegovy, ...